Arrhythmias, Cardiac
Arrhythmia, Sinus
Electrocardiography
Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.
Tachycardia, Ventricular
An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Ventricular Fibrillation
A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
Ventricular Premature Complexes
A type of cardiac arrhythmia with premature contractions of the HEART VENTRICLES. It is characterized by the premature QRS complex on ECG that is of abnormal shape and great duration (generally >129 msec). It is the most common form of all cardiac arrhythmias. Premature ventricular complexes have no clinical significance except in concurrence with heart diseases.
Heart Conduction System
Tachycardia
Electrocardiography, Ambulatory
Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.
Cardiac Complexes, Premature
Death, Sudden, Cardiac
Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
Long QT Syndrome
A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Atrial Fibrillation
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Tachycardia, Supraventricular
Electrophysiologic Techniques, Cardiac
Atrial Flutter
Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
Defibrillators, Implantable
Catheter Ablation
Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias.
Heart Ventricles
Cardiac Pacing, Artificial
Flecainide
Torsades de Pointes
A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.
NAV1.5 Voltage-Gated Sodium Channel
Dogs
Electric Countershock
Amiodarone
Action Potentials
Myocardium
Myocytes, Cardiac
Digitalis Glycosides
Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.
Myocardial Ischemia
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Bradycardia
Models, Cardiovascular
Aconitine
Myocardial Infarction
Death, Sudden
Atrial Premature Complexes
A type of cardiac arrhythmia with premature atrial contractions or beats caused by signals originating from ectopic atrial sites. The ectopic signals may or may not conduct to the HEART VENTRICLES. Atrial premature complexes are characterized by premature P waves on ECG which are different in configuration from the P waves generated by the normal pacemaker complex in the SINOATRIAL NODE.
Body Surface Potential Mapping
Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. (Braunwald, Heart Disease, 4th ed)
Propafenone
Myocardial Reperfusion Injury
Heart Block
Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.
Ether-A-Go-Go Potassium Channels
A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration.
Stereoisomerism
Encainide
Electrophysiology
Follow-Up Studies
Voltage-Sensitive Dye Imaging
Telemetry
Syncope
A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
Treatment Outcome
Pericardium
A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.
Cardiac Electrophysiology
Tachycardia, Ectopic Atrial
Abnormally rapid heartbeats originating from one or more automatic foci (nonsinus pacemakers) in the HEART ATRIUM but away from the SINOATRIAL NODE. Unlike the reentry mechanism, automatic tachycardia speeds up and slows down gradually. The episode is characterized by a HEART RATE between 135 to less than 200 beats per minute and lasting 30 seconds or longer.
Cardiomyopathies
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Tetralogy of Fallot
A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.
Sodium Channels
Pacemaker, Artificial
Connexin 43
Mexiletine
Quinidine
An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.
Risk Factors
Disopyramide
Atrioventricular Block
Tachycardia, Sinus
Disease Models, Animal
Adrenergic beta-Antagonists
Magnetic Resonance Spectroscopy
Arrhythmogenic Right Ventricular Dysplasia
Autonomic Nervous System
The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
Heart Failure
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Prospective Studies
Potassium Channels, Voltage-Gated
Epinephrine
The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
Heart Diseases
Echocardiography
Refractory Period, Electrophysiological
The period of time following the triggering of an ACTION POTENTIAL when the CELL MEMBRANE has changed to an unexcitable state and is gradually restored to the resting (excitable) state. During the absolute refractory period no other stimulus can trigger a response. This is followed by the relative refractory period during which the cell gradually becomes more excitable and the stronger impulse that is required to illicit a response gradually lessens to that required during the resting state.
Lidocaine
Atrioventricular Node
Wolff-Parkinson-White Syndrome
A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
Nucleic Acid Conformation
Epicardial Mapping
Retrospective Studies
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Cardiomyopathy, Dilated
Heart Arrest
Molecular Structure
Signal Processing, Computer-Assisted
Models, Molecular
Rabbits
Pulmonary Veins
Acetanilides
Postoperative Complications
Potassium Channels
Purkinje Fibers
Digitalis
Ryanodine Receptor Calcium Release Channel
A tetrameric calcium release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and cardiac excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.
Sinoatrial Node
The small mass of modified cardiac muscle fibers located at the junction of the superior vena cava (VENA CAVA, SUPERIOR) and right atrium. Contraction impulses probably start in this node, spread over the atrium (HEART ATRIUM) and are then transmitted by the atrioventricular bundle (BUNDLE OF HIS) to the ventricle (HEART VENTRICLE).
Tachycardia, Atrioventricular Nodal Reentry
Abnormally rapid heartbeats caused by reentry of atrial impulse into the dual (fast and slow) pathways of ATRIOVENTRICULAR NODE. The common type involves a blocked atrial impulse in the slow pathway which reenters the fast pathway in a retrograde direction and simultaneously conducts to the atria and the ventricles leading to rapid HEART RATE of 150-250 beats per minute.
Hemodynamics
Vagus Nerve
The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).
Predictive Value of Tests
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Ventricular Function, Left
Rats, Wistar
Hydrogen Bonding
Cardiotonic Agents
Halothane
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)
Stroke Volume
Anesthesia
Heart Defects, Congenital
Bundle of His
Small band of specialized CARDIAC MUSCLE fibers that originates in the ATRIOVENTRICULAR NODE and extends into the membranous part of the interventricular septum. The bundle of His, consisting of the left and the right bundle branches, conducts the electrical impulses to the HEART VENTRICLES in generation of MYOCARDIAL CONTRACTION.
Propranolol
Stellate Ganglion
Andersen Syndrome
A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.
Coronary Disease
Sick Sinus Syndrome
A condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.
Hypokalemia
Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
Heterocyclic Compounds, Bridged-Ring
Electrophysiological Phenomena
Plant Extracts
Bundle-Branch Block
Calcium Signaling
Signal transduction mechanisms whereby calcium mobilization (from outside the cell or from intracellular storage pools) to the cytoplasm is triggered by external stimuli. Calcium signals are often seen to propagate as waves, oscillations, spikes, sparks, or puffs. The calcium acts as an intracellular messenger by activating calcium-responsive proteins.
Base Pairing
Pachyrhizus
Myocardial Reperfusion
Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.
Exercise Test
Ventricular Dysfunction, Left
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
Gap Junctions
Connections between cells which allow passage of small molecules and electric current. Gap junctions were first described anatomically as regions of close apposition between cells with a narrow (1-2 nm) gap between cell membranes. The variety in the properties of gap junctions is reflected in the number of CONNEXINS, the family of proteins which form the junctions.
Dose-Response Relationship, Drug
Isoproterenol
Cardiomyopathy, Hypertrophic
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
Risk Assessment
Potassium
An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
Patch-Clamp Techniques
An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.
Calcium
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Incidence
Sarcoplasmic Reticulum
Ajmaline
Guinea Pigs
Potassium Channel Blockers
Sodium-Calcium Exchanger
Calsequestrin
Isolated Noncompaction of the Ventricular Myocardium
Rare congenital cardiomyopathies characterized by the lack of left ventricular myocardium compaction. The noncompaction results in numerous prominent trabeculations and a loose myocardial meshwork (spongy myocardium) in the LEFT VENTRICLE. Heterogeneous clinical features include diminished systolic function sometimes associated with left ventricular dilation, that presents either neonatally or progressively. Often, the RIGHT VENTRICLE is also affected. CONGESTIVE HEART FAILURE; PULMONARY EMBOLISM; and ventricular ARRHYTHMIA are commonly seen.
Monitoring, Physiologic
DNA
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Astemizole
Butylscopolammonium Bromide
Heterocyclic Compounds with 4 or More Rings
Tachycardia, Ectopic Junctional
A rare form of supraventricular tachycardia caused by automatic, not reentrant, conduction initiated from sites at the atrioventricular junction, but not the ATRIOVENTRICULAR NODE. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication with a HEART RATE ranging from 140 to 250 beats per minute.
Aprindine
Prognosis
Propanolamines
Ventricular Dysfunction, Right
A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.
Guanosine
Sodium Channel Blockers
KCNQ Potassium Channels
Pre-Excitation Syndromes
A group of conditions in which HEART VENTRICLE activation by the atrial impulse is faster than the normal impulse conduction from the SINOATRIAL NODE. In these pre-excitation syndromes, atrial impulses often bypass the ATRIOVENTRICULAR NODE delay and travel via ACCESSORY CONDUCTING PATHWAYS connecting the atrium directly to the BUNDLE OF HIS.
Calcium Channels, L-Type
Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.
Sympathetic Nervous System
The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
Chlorofluorocarbons, Methane
Magnesium Sulfate
A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Plants, Medicinal
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Cisapride
Mutation
Disease Susceptibility
Phenethylamines
Digoxin
A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
Terfenadine
Computer Simulation
G-Quadruplexes
Higher-order DNA and RNA structures formed from guanine-rich sequences. They are formed around a core of at least 2 stacked tetrads of hydrogen-bonded GUANINE bases. They can be formed from one two or four separate strands of DNA (or RNA) and can display a wide variety of topologies, which are a consequence of various combinations of strand direction, length, and sequence. (From Nucleic Acids Res. 2006;34(19):5402-15)
Ouabain
Antibodies
Excitation Contraction Coupling
The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation. (1/3137)
1. Arachidonic acid (0.01-1 microM) induced relaxation of precontracted rings of rabbit saphenous vein, which was counteracted by contraction at concentrations higher than 1 microM. Concentrations higher than 1 microM were required to induce dose-dependent contraction of vena cava and thoracic aorta from the same animals. 2. Pretreatment with a TP receptor antagonist (GR32191B or SQ29548, 3 microM) potentiated the relaxant effect in the saphenous vein, revealed a vasorelaxant component in the vena cava response and did not affect the response of the aorta. 3. Removal of the endothelium from the venous rings, caused a 10 fold rightward shift in the concentration-relaxation curves to arachidonic acid. Whether or not the endothelium was present, the arachidonic acid-induced relaxations were prevented by indomethacin (10 microM) pretreatment. 4. In the saphenous vein, PGE2 was respectively a 50 and 100 fold more potent relaxant prostaglandin than PGI2 and PGD2. Pretreatment with the EP4 receptor antagonist, AH23848B, shifted the concentration-relaxation curves of this tissue to arachidonic acid in a dose-dependent manner. 5. In the presence of 1 microM arachidonic acid, venous rings produced 8-10 fold more PGE2 than did aorta whereas 6keto-PGF1alpha and TXB2 productions remained comparable. 6. Intact rings of saphenous vein relaxed in response to A23187. Pretreatment with L-NAME (100 microM) or indomethacin (10 microM) reduced this response by 50% whereas concomitant pretreatment totally suppressed it. After endothelium removal, the remaining relaxing response to A23187 was prevented by indomethacin but not affected by L-NAME. 7. We conclude that stimulation of the cyclo-oxygenase pathway by arachidonic acid induced endothelium-dependent, PGE2/EP4 mediated relaxation of the rabbit saphenous vein. This process might participate in the A23187-induced relaxation of the saphenous vein and account for a relaxing component in the response of the vena cava to arachidonic acid. It was not observed in thoracic aorta because of the lack of a vasodilatory receptor and/or the poorer ability of this tissue than veins to produce PGE2. (+info)Preconditioning in immature rabbit hearts: role of KATP channels. (2/3137)
BACKGROUND: The protective effects of ischemic preconditioning have been shown to occur in adult hearts of all species studied. We determined whether immature hearts normoxic or chronically hypoxic from birth could be preconditioned, the time window or memory of the cardioprotective effect, and the involvement of the KATP channel. METHODS AND RESULTS: Isolated immature rabbit hearts (7 to 10 days old) were subjected to 0, 1, or 3 cycles of preconditioning consisting of 5 minutes of global ischemia plus 10 minutes of reperfusion. This was followed by 30 minutes of global ischemia and 35 minutes of reperfusion. Normoxic hearts (FIO2=0.21) subjected to 1 cycle of preconditioning recovered 70+/-7% of left ventricular developed pressure compared with 43+/-8% recovery in nonpreconditioned controls. Three cycles of preconditioning did not result in additional recovery (63+/-8%). Hearts from rabbits raised from birth in hypoxic conditions (FIO2=0.12) and subjected to 1 and 3 preconditioning cycles did not show increased recovery (68+/-8% and 65+/-5%) compared with nonpreconditioned hypoxic controls (63+/-9%), although the recovery was greater in chronically hypoxic hearts than in age-matched normoxic controls. Increasing the recovery period after the preconditioning stimulus from 10 to 30 minutes resulted in a loss of cardioprotection. Pretreatment of normoxic hearts for 30 minutes with the KATP channel blocker 5-hydroxydecanoate (300 micromol/L) completely abolished preconditioning (70+/-7% to 35+/-9%) but had no effect on nonpreconditioned hearts (40+/-8%). CONCLUSIONS: Immature hearts normoxic from birth can be preconditioned, whereas immature hearts hypoxic from birth cannot. Preconditioning in normoxic immature hearts is associated with activation of the KATP channel. (+info)Modulation of AV nodal and Hisian conduction by changes in extracellular space. (3/3137)
Previous studies have demonstrated that the extracellular space (ECS) component of the atrioventricular (AV) node and His bundle region is larger than the ECS in adjacent contractile myocardium. The potential physiological significance of this observation was examined in a canine blood-perfused AV nodal preparation. Mannitol, an ECS osmotic expander, was infused directly into either the AV node or His bundle region. This resulted in a significant dose-dependent increase in the AV nodal or His-ventricular conduction time and in the AV nodal effective refractory period. Mannitol infusion eventually resulted in Wenckebach block (n = 6), which reversed with mannitol washout. The ratio of AV nodal to left ventricular ECS in tissue frozen immediately on the development of heart block (n = 8) was significantly higher in the region of block (4.53 +/- 0.61) compared with that in control preparations (2.23 +/- 0.35, n = 6, P < 0.01) and donor dog hearts (2.45 +/- 0.18, n = 11, P < 0.01) not exposed to mannitol. With lower mannitol rates (10% of total blood flow), AV nodal conduction times increased by 5-10% and the AV node became supersensitive to adenosine, acetylcholine, and carbachol, but not to norepinephrine. We conclude that mannitol-induced changes in AV node and His bundle ECS markedly alter conduction system electrophysiology and the sensitivity of conductive tissues to purinergic and cholinergic agonists. (+info)Delayed rectifier potassium current in undiseased human ventricular myocytes. (4/3137)
OBJECTIVE: The purpose of the study was to investigate the properties of the delayed rectifier potassium current (IK) in myocytes isolated from undiseased human left ventricles. METHODS: The whole-cell configuration of the patch-clamp technique was applied in 28 left ventricular myocytes from 13 hearts at 35 degrees C. RESULTS: An E-4031 sensitive tail current identified the rapid component of IK (IKr) in the myocytes, but there was no evidence for an E-4031 insensitive slow component of IK (IKs). When nifedipine (5 microM) was used to block the inward calcium current (ICa), IKr activation was fast (tau = 31.0 +/- 7.4 ms, at +30 mV, n = 5) and deactivation kinetics were biexponential and relatively slow (tau 1 = 600.0 +/- 53.9 ms and tau 2 = 6792.2 +/- 875.7 ms, at -40 mV, n = 7). Application of CdCl2 (250 microM) to block ICa altered the voltage dependence of the IKr considerably, slowing its activation (tau = 657.1 +/- 109.1 ms, at +30 mV, n = 5) and accelerating its deactivation (tau = 104.0 +/- 18.5 ms, at -40 mV, n = 8). CONCLUSIONS: In undiseased human ventricle at 35 degrees C IKr exists having fast activation and slow deactivation kinetics; however, there was no evidence found for an expressed IKs. IKr probably plays an important role in the frequency dependent modulation of repolarization in undiseased human ventricle, and is a target for many Class III antiarrhythmic drugs. (+info)Electrophysiologic effect of enalapril on guinea pig papillary muscles in vitro. (5/3137)
AIM: To study the direct effect of enalapril on cellular electrophysiology of myocardium. METHODS: Conventional microelectrodes technique was used to record the action potentials (AP) of guinea pig papillary muscles. RESULTS: Enalapril caused an increase of the AP amplitude (APA) and the resting potential (RP) in a concentration-dependent manner without any significant change of AP duration, Vmax and overshoot of AP. Superfusion of ouabain 0.5 mumol.L-1 reduced APA and RP, induced stable delayed after-depolarizations (DAD) at different basic cycle lengths (BCL) in a frequency-dependent manner. At BCL 200 ms, the amplitude of DAD was large enough to induce nonsustained triggered activity (TA). In additional presence of enalapril 10 mumol.L-1, the DAD amplitude at 500, 400, 300, and 200 ms were decreased from 5.3 +/- 2.3, 5.9 +/- 2.8, 7.4 +/- 2.1, and 8.9 +/- 1.3 to 2.6 +/- 0.7, 3.1 +/- 1.0, 3.7 +/- 1.5, and 5.3 +/- 1.1 (mV) respectively, all P < 0.01. The compensation intervals were increased in a similar frequency-dependent manner. The number of TA induced at BCL 200 ms was decreased from 3.6 +/- 0.7 to 0.8 +/- 0.2 (P < 0.05). CONCLUSION: Enalapril directly inhibits DAD and TA induced by ouabain through increasing RP and APA, which may contribute to its anti-arrhythmic effect. (+info)Effects of dauricine, quinidine, and sotalol on action potential duration of papillary muscles in vitro. (6/3137)
AIM: To compare the characteristics of dauricine, sotalol, and quinidine on action potential duration (APD). METHODS: Using intracellular microelectrode method to record APD in guinea pig papillary muscles. RESULTS: Dauricine 20 mumol.L-1 prolonged action potential at 90% repolarization, the percent of APD prolongation were 22 +/- 8, 11 +/- 6, 9 +/- 5, 7 +/- 5, 6 +/- 3, 4.3 +/- 2.8, 4.5 +/- 2.8 at the cycle lengths of 200-2000 ms, dauricine became more effective in lengthening APD at short cycle lengths. The effect of dauricine on prolonging APD exhibited normal use-dependence, whereas quinidine 1 mumol.L-1 and sotalol 10 mumol.L-1 were less effective in lengthening APD at short cycle lengths. The effect of quinidine and sotalol on APD exhibited reverse use-dependence. CONCLUSSION: The effect of dauricine on APD depends on activation frequency. (+info)Imipramine blocks the transient outward potassium current in rat ventricular myocytes. (7/3137)
AIM: To examine the effects of imipramine on transient outward potassium current (I(to) in rat ventricular myocytes. METHODS: The patch-clamp whole-cell recording techniques were used. RESULTS: Imipramine resulted in a concentration-dependent inhibition of I(to) with the IC50 of 6.0 mumol.L-1 and a concentration-dependent acceleration of I(to) inactivation. The blocking showed no difference at different testing membrane potentials. Imipramine produced slight effects (about 3 and 4 mV, respectively) on steady-state activation and inactivation curves of I(to), and tended to prolong the recovery of I(to) from inactivation (tau control = 37 +/- 11 ms; tau drug = 58 +/- 17 ms), but not significant (n = 4, P > 0.05). The inhibitory effect of imipramine on Ito was increased when the prepulses were prolonged progressively from 0 to 120 ms. (tau control = 22 +/- 8 ms; tau drug = 14 +/- 5 ms). CONCLUSIONS: Imipramine blocked Ito in concentration-dependent but voltage-independent manners, and with "open channel blocking" properties. (+info)Effects of cycloprotobuxine-A on atrial fibrillation. (8/3137)
AIM: To study the effects of cycloprotobuxine-A (Cyc-A) on atrial fibrillation. METHODS: Atrial fibrillations in vivo and in vitro were induced by arrhythmogenic drugs. Action potentials were measured by the standard microelectrode technique. RESULTS: Cyc-A, similar to or slightly stronger than amiodarone (Ami), decreased incidences of atrial fibrillation elicited by CaCl2-acetylcholine in mice and increased doses of aconitine, ouabain, or adrenaline to elicit atrial fibrillation in isolated guinea pig atria. Cyc-A 0.3-100 mumol.L-1 decreased the normal automaticity and 0.3-30 mumol.L-1 attenuated or almost abolished the isoprenaline-induced abnormal increase in automaticity in sinus nodal cells. In isolated left atria, Cyc-A 0.3-30 mumol.L-1 inhibited the abnormal rhythmic activity elicited by adrenaline, prolonged action potential duration (APD) and effective refractory period, and reduced excitability. At 3-30 mumol.L-1, Cyc-A also decreased the maximal velocity of depolarization (Vmax). Cyc-A antagonized the acetylcholine-induced shortening of APD. These electrophysiologic effects were similar to those of amiodarone, but Ami did not affect the Vmax. CONCLUSION: Cyc-A produces a protective effect against experimental atrial fibrillation via a prolongation of repolarization, a decease of automaticity, and an inhibition of excitability. (+info)
Antiarrhythmic medication - definition of antiarrhythmic medication by The Free Dictionary
antiarrhythmic medications - Symptoms, Treatments and Resources for antiarrhythmic medications
US Patent for N-aminoalkylperfluoroalkanoylaminobenzene-sulfonamide anti-arrhythmic agents Patent (Patent # 4,794,196 issued...
PRIME PubMed | Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by...
A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation ...
Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic...
Vernakalant: Pharmacology, electrophysiology, safety and efficacy<...
Anti-Arrhythmic Drugs | Goodman and Gilmans Manual of Pharmacology and Therapeutics, 2e | AccessBiomedical Science | McGraw...
Antiarrhythmic medication - Doctors answer your questions
Synthesis, reactions, and antiarrhythmic activities of some novel pyrimidines and pyridines fused with thiophene moiety
Classification of antiarrhythmic drugs in relation to mechanisms of arrhythmias | SpringerLink
Antiarrhythmic Agents the script Flashcards - Cram.com
Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic...
Therapeutic Drug Monitoring of Antiarrhythmic Drugs: Rationale and Current Status<...
Poisoning Due to Class 1B Antiarrhythmic Drugs | SpringerLink
Antiarrhythmics | Heart and Stroke Foundation
Antiarrhythmic agent
Management of acute intradialytic cardiovascular complications: Updated overview (Review)
Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 :Market Segments, Size, Trend and Market...
Block 3: Antiarrhythmics Flashcards - Cram.com
Experiences with Heart Attack and Antiarrhythmic Medicines | FoundHealth
Choosing Antiarrhythmics
Antiarrhythmics - WikEM
Betapace - Description - What we offer is best choice of First-Hand Meds in Canada - from ED drugs to antibiotics!
Medications
Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study | JACC: Journal of the American College of...
Atrial Fibrillation Follow-up Investigation of Rhythm Management - American College of Cardiology
III drugs
Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation - Tabular View -...
KIT - Bachelor-, Master- und Doktorarbeiten - Modeling the Impact of Dronedarone on Human Atrial Electrophysiology in Healthy...
Study of making pseudoephedrine a Class III drug and needing a prescription to obtain. :: Documents.OK.Gov
Tedisamil - Wikipedia
Disopyramide - Wikipedia
Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the...
codali.be
Advances in Antiarrhythmic Drug Therapy, An Issue of Cardiac Electrophysiology Clinics, Volume 2-3 - 1st Edition
Major side effects of class I antiarrhythmic drugs
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties | Circulation
Plus it
Flecainide Acetate Coupon - Save 52% w/ Coupons - September 2021
Status of Antiarrhythmic Drug Development for Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology
ARCA biopharma Release: GencaroTM Demonstrated 74% Risk Reduction for New Onset Atrial Fibrillation in Heart Failure Patients...
18 Cardiac Arrhythmias | Thoracic Key
Labaz
-
Vasodilator Agents, Enzyme Inhibitors, Anti-Arrhythmia Agents, ATC:C01BD01
Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? - Radcliffe Department of Medicine
A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation - Full Text...
Atrial electrophysiological effects of ibutilide infusion in humans. - Semantic Scholar
Do Anti-Ischemic Medications Have a Role in the Treatment of Ventricular Tachyarrhythmias? - American College of Cardiology
Cardiovascular effects of marine omega-3 fatty acids - Review - publication pdf attached
Landiolol - Self-sufficiency
Plus it
Quinidine (Oral route, injection route, intramuscular route)
Effect of smoking on atrial fibrillation - Doctors insight on HealthcareMagic
Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta...
Amiodarone | CTD
Antiarrhythmics - STEP1 Cardiovascular - Step 1 - Medbullets.com
How Much Ivermectin Paste Can A Human Take - Ivermectin for humans in india : Banglalista
Amiodarone - Pharmaceutical Information, Clinical Trials, Detailed Pharmacology, Toxicology.
Update on Atrial Fibrillation Stroke Prevention-Video interview with Dr. Daniel Singer of Harvard - Atrial Fibrillation Info...
Flecainide (Flecainide Acetate) Qualimed Pharma
Drug treatment of atrial fibrillation in the managed care era. | Base documentaire | BDSP
Antiarrhythmics & Heart Failure
Amiodarone Uses, Dosage & Side Effects - Drugs.com
Pharmacological activity and membrane interactions of antiarrhythmics: 4D-QSAR/QSPR analysis
Nadoxolol
Warembourg, H; Ducloux, G (1976). "Clinical study of a new anti-arrhythmia agent: nadoxolol". Lille Med. 21 (4): 386-8. PMID ... Nadoxolol is an antiarrhythmic agent (i.e., a drug for the treatment of irregular heartbeat), chemically related in structure ... Antiarrhythmic agents, 1-Naphthyl compounds, All stub articles, Cardiovascular system drug stubs). ...
Cymarin
... is a cardiac glycoside and an anti-arrhythmia and cardiotonic agent. Tilford GL. Edible and Medicinal plants of the ...
Effective refractory period
Anti-arrhythmic agents used for arrhythmias usually prolong the ERP. For the treatment of atrial fibrillation, it is a problem ... that the prolongation of the ERP by these agents also affects the ventricles, which can induce other types of arrhythmias. ( ... ERP acts as a protective mechanism and keeps the heart rate in check and prevents arrhythmias, and it helps coordinates muscle ...
Procainamide
... works as an anti-arrhythmic agent and is used to treat cardiac arrhythmia. It induces rapid block of the ... Procainamide is used for treating ventricular arrhythmias: ventricular ectopy and tachycardia and supraventricular arrhythmias ... Procainamide (PCA) is a medication of the antiarrhythmic class used for the treatment of cardiac arrhythmias. It is classified ... It was found that procainamide was effective for treating ventricular arrhythmias, but it had the same toxicity profile as ...
HBI-3000
... the intravenous injection of HBI-3000 demonstrated to be an effective anti-arrhythmic and anti-fribrillatory agent. The ... The most common chronic arrhythmia is atrial fibrillation. There is an increased incidence of atrial fibrillation in the ... Anti-arrhythmic medication is taken to treat irregular beating of the heart. This irregular beating results from a deregulation ... Most anti-arrhythmic medications exert their effects by decreasing the permeability of potassium ion channels (IKr) in heart ...
AZD1305
Available anti-arrhythmic agents (AAD) used for the maintenance of AF are often accompanied with the risk of developing ... AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias, ... The combined block of INa, IKr, and L-type calcium current is key to the anti-arrhythmic potential of AZD1305 compared IKr ... AZD1305 possesses class III anti-arrhythmic activity by blocking the human ether-a-go-go-related gene (hERG) potassium channel ...
Hyoscyamine
When hyoscyamine is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially ... arrhythmia, flushing, and faintness. An overdose will cause headache, nausea, vomiting, and central nervous system symptoms ... and Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Among Patients Attending a Free Clinic". Journal of Patient Experience. 7 (6 ...
Bradykinin
Stewart JM (2003). "Bradykinin antagonists as anti-cancer agents". Current Pharmaceutical Design. 9 (25): 2036-42. doi:10.2174/ ... arrhythmia and sudden cardiac death. A bradykinin-potentiating factor (BPF) which increases both the duration and magnitude of ... and bradykinin antagonists have been investigated as anti-cancer agents. Bradykinin has been proposed as an explanation for ...
Tedisamil
Atrial arrhythmias are the most common type of arrhythmia with several subtypes currently described, including atrial ... Fox KM, Henderson JR, Kaski JC, Sachse A, Kuester L, Wonnacott S (February 2000). "Antianginal and anti-ischaemic efficacy of ... is an experimental class III antiarrhythmic agent currently being investigated for the treatment of atrial fibrillation. ... Arrhythmias are broadly defined as abnormal electrical activity in the heart and can affect both the atria and ventricles. ...
Outline of cardiology
Cardiac arrhythmias - conditions in which the heartbeat is irregular, too fast, or too slow. Many types of arrhythmia have no ... Perhaps the most prominent manipulation of ion channels is through antiarrhythmic agents. These agents are commonly classified ... SSRI's also have interactions with anti-coagulation therapy and increases the risk of bleeding while on them. Serotonin- ... A common arrhythmia that can lead to this form of cardiomyopathy is the common atrial fibrillation. Takotsubo cardiomyopathy ( ...
Celivarone
... a drug commonly used to treat arrhythmias. Celivarone has potential as an antiarrhythmic agent, attributable to its ... "In vivo and in vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-adrenergic, and ... Cardiac arrhythmia is any abnormality in the electrical activity of the heart. Arrhythmias range from mild to severe, sometimes ... Since it affects multiple ion channels, it also shows promise in treating genetic forms of arrhythmia caused by several ion ...
Azimilide
Although each agent has its own properties and will have thus a different function. Azimilide dihydrochloride is a ... Most recent clinical trials have investigated the use of azimilide in reducing the frequency and severity of arrhythmias in ... Azimilide has been studied for its anti-arrhythmic effects: its converts and maintains sinus rhythm in patients with atrial ... Azimilide is a class ΙΙΙ antiarrhythmic drug (used to control abnormal heart rhythms). The agents from this heterogeneous group ...
Acecainide
It is a Class III antiarrhythmic agent, whereas procainamide is a Class Ia antiarrhythmic drug. It is only partially as active ... During and after his surgery he was facing problems with arrhythmias. These problems were investigated by Frederick R. Mautz. ... Measuring the ratio of acecainide and procainamide concentrations together helps to achieve an optimum anti-arrhythmic effect ... In patients who are refractory to other antiarrhythmic agents, the doses required appear to be greater. Moreover, a few studies ...
Antiarrhythmic agent
Class II agents are anti-sympathetic nervous system agents. Most agents in this class are beta blockers. Class III agents ... Cardiac Arrhythmia Suppression Trial (CAST) Electrocardiogram Antiarrhythmic agents (category) Proarrhythmic agent Rang, ... Class IV agents affect calcium channels and the AV node. Class V agents work by other or unknown mechanisms. With regard to ... Class I agents are called membrane-stabilizing agents, "stabilizing" referring to the decrease of excitogenicity of the plasma ...
Dimeditiapramine
Tiapamil has been described as an "antianginal agent". It exhibits properties of anti-arrhythmic medications. These are ... It can treat ventricular arrhythmias to a higher degree than traditional calcium antagonists. Verapamil Cocco, G.; Strozzi, C ... It is another calcium antagonist and anti-hypertensive. The two drugs have similar properties, however, Dimeditiapramine ...
List of MeSH codes (D27)
... uricosuric agents MeSH D27.505.954.411 - cardiovascular agents MeSH D27.505.954.411.097 - anti-arrhythmia agents MeSH D27.505. ... anti-allergic agents MeSH D27.505.954.122 - anti-infective agents MeSH D27.505.954.122.085 - anti-bacterial agents MeSH D27.505 ... antiviral agents MeSH D27.505.954.122.388.077 - anti-retroviral agents MeSH D27.505.954.122.388.077.088 - anti-hiv agents MeSH ... tranquilizing agents MeSH D27.505.696.277.950.015 - anti-anxiety agents MeSH D27.505.696.277.950.025 - antimanic agents MeSH ...
Glycoside
... other agents are now preferred[citation needed]) and arrhythmia. These sweet glycosides found in the stevia plant Stevia ... Their medicinal value is due to their expectorant, corticoid and anti-inflammatory effects. Steroid saponins are important ... Saponins are also natural ruminal antiprotozoal agents that are potential to improve ruminal microbial fermentation reducing ... and anti-inflammatory effects. These glycosides contain an aglycone group that is a derivative of anthraquinone. They have a ...
Potassium-sparing diuretic
They can be used in combination with other anti-hypertensives or drugs that cause hypokalemia to help maintain a normal range ... C03D Potassium-sparing agents Rose BD (February 1991). "Diuretics". Kidney Int. 39 (2): 336-52. doi:10.1038/ki.1991.43. PMID ... which risks potentially fatal arrhythmias. Triamterene, specifically, is a potential nephrotoxin and up to half of the patients ... are anti-hypertensive drugs with diuretic effects that decrease renal excretion of potassium. They work by inhibiting either ...
Performance-enhancing substance
"U.S. Anti-Doping Agency - USADA". U.S. Anti-Doping Agency (USADA). Retrieved 3 November 2015. Media related to Ergogenic aids ... Urine samples can be tested via electrophoresis, and blood samples via indirect markers.[example needed] Gene doping agents are ... Potential side effects include: hypertension, insomnia, headaches, weight loss, arrhythmia, tremors, anxiety, addiction, and ... The 1988 Anti-Drug Abuse Act and 1990 Anabolic Steroid Act both deemed anabolic steroids as an illegal substance when not used ...
Acute coronary syndrome
The most common type of cardiac arrhythmia is atrial fibrillation.[citation needed] Many anti-arrhythmic drugs have side ... In patients who has been administered with digitalis agents (digoxin, methyl-digoxin), the vasoconstrictor dose should be ... and the nature of the arrhythmia. If arrhythmia develops during dental treatment, the procedure should be suspended, oxygen is ... Mechanical mitral valves are prone to thrombosis, which cause emboli if adequate anti-coagulation is not maintained, although ...
Alexandra Chaves
At age 12, she was diagnosed with heart arrhythmia that meant she would need to take a nine-month break from dancing. "Mini ... As part of her work with The Next Step, Chaves has participated in Family Channel's Stand Up! anti-bullying campaign. In 2017, ... Hill, Valerie (June 7, 2017). "Five triple-threat dance students from Kitchener catching the attention of talent agents". ...
Magnesium sulfate (medical use)
... agent for torsades de pointes in cardiac arrest under the ECC guidelines and for managing quinidine-induced arrhythmias. ... Magnesium sulfate was once used as a tocolytic, but meta-analyses have failed to support it as an anti-contraction medication. ... Magnesium sulfate may be used as bronchodilator after beta-agonist and anticholinergic agents have been tried, e.g. in severe ...
Pharmacotoxicology
Anti-depressants have been prescribed since the 1950s, and their prevalence has significantly increased since then. There are ... Doxorubicin is an uncoupling agent in that it inhibits proper functioning of complex I of the electron transport chain in ... but have high incidences of cardiac arrhythmias and myocardial infarctions. Guengerich, F. Peter (2011). "Mechanisms of Drug ... Other anti-cancer drugs, such as fluoropyrimidines and taxanes, are extremely effective at treating and reducing tumor ...
Hydroxychloroquine
It may have both an anti-spirochete activity and an anti-inflammatory activity, similar to the treatment of rheumatoid ... Both agents also inhibit CYP2D6 activity and may interact with other medications that depend on this enzyme. Antimalarials are ... ventricular arrhythmias) if used concurrently) Mefloquine and other drugs known to lower the seizure threshold (co- ... After World War I, the German government sought alternatives to quinine as an anti-malarial. Chloroquine, a synthetic analogue ...
Paroxysmal supraventricular tachycardia
SVT that does not involve the AV node may respond to other anti-arrhythmic drugs such as sotalol or amiodarone.[citation needed ... "Types of Arrhythmia". NHLBI. July 1, 2011. Archived from the original on June 7, 2015. Retrieved September 29, 2016. "BestBets ... Adenosine, an ultra-short-acting AV nodal blocking agent, is indicated if vagal maneuvers are not effective. If unsuccessful or ... "What Are the Signs and Symptoms of an Arrhythmia?". NHLBI. July 1, 2011. Archived from the original on 19 February 2015. ...
5-HT3 antagonist
Galanolactone, a diterpenoid found in ginger, is a 5-HT3 antagonist and is believed to at least partially mediate the anti- ... Pasricha, Pankaj J. (2006). "Treatment of Disorders of Bowel Motility and Water Flux; Antiemetics; Agents Used in Biliary and ... such as prolongation of the PT and QTc intervals and certain arrhythmias. The clinical significance of these side effects is ... 1991). "Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger". Chem Pharm Bull. 39 (2): 397-9. ...
Amiodarone
It is used both in supraventricular arrhythmias and ventricular arrhythmias.[citation needed] Defibrillation is the treatment ... Amiodarone also causes an anti-thyroid action, via Plummer and Wolff-Chaikoff effects, due its large amount of iodine in its ... Common practice is to avoid the agent if possible in individuals with decreased lung function. The most specific test of ... In some people, daily use of amiodarone at 100 mg oral doses can be effective for arrhythmia control with no or minimal side ...
Ranitidine
2005). "Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients". FASEB J. 19 (6): 656-658. doi: ... Arrhythmias such as tachycardia, bradycardia, atrioventricular block, and premature ventricular beats have also been reported. ... Patients who take these agents develop higher levels of immunoglobulin E against food, whether they had prior antibodies or not ... Relief of heartburn Short-term and maintenance therapy of gastric and duodenal ulcers With nonsteroidal anti-inflammatory drugs ...
Palmatine
In addition, palmatine also had anti-cancer activity on MCF-7, U251, KB, CHOK-1, HT-29 and SiHacell lines. Palmatine induced ... "Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME ... "Synthesis and Cytotoxicity Evaluation of 13-n-Alkyl Berberine and Palmatine Analogues as Anticancer Agents". Molecules. 17 (10 ... Study showed, that palmatine can decrease the production of pro-inflammatory factors and increase the production of anti- ...
Diallyl trisulfide
H2S is a cardioprotective agent that has antioxidant, anti-inflammatory, and anti-apoptotic effects,. A major topic of research ... DATS is a promising treatment for cardiac arrhythmias through its ability to change the opening of the human ether-à-go-go- ... However, hERG trafficking impairment has also been shown to cause arrhythmias due to the development of long QT syndrome and ...
Doxepin
Antiarrhythmic agents may be an appropriate measure to treat cardiac arrhythmias resulting from doxepin overdose. Slow ... In general, sedating properties of anti-depressant agents are related to antagonism of serotonin 5HT2, histamines, and α-1 ... Sympathomimetic agents may have their effects potentiated by TCAs like doxepin. Doxepin also may potentiate the adverse effects ... Antihypertensive agents may have their effects mitigated by doxepin. Cotreatment with CNS depressants such as the ...
Pheochromocytoma
The selective agents (atenolol, metoprolol) are preferred to the non-selective agents (propranolol). There are several ( ... Arrhythmias: Sinus tachycardia is the most common abnormal heart rhythm associated with a pheochromocytoma and is experienced ... Furthermore, over a fourth of the patients were able to decrease their anti-hypertensive medications and reported symptomatic ... These agents should be avoided whenever possible as there is upwards of seven times more beta-adrenoceptor antagonism than ...
Generalized anxiety disorder
"Citalopram versus other anti-depressive agents for depression". The Cochrane Database of Systematic Reviews (7): CD006534. doi: ... arrhythmia and unconsciousness. SNRIs like SSRIs carry a black box warning for suicidal ideation, but it is generally ... Like other serotonergic agents, SNRIs have the potential to cause serotonin syndrome, a potentially fatal systemic response to ... Overdose of an SSRI or concomitant use with another agent that causes increased levels of serotonin can result in serotonin ...
Christopher Busby
He was not arrested in connection with the nerve agent attack but after two police officers felt unwell in his house. He was ... They observed that, while caesium-137 exposure did not cause any damage to heart cells or arrhythmias, results indicated that ... A Japanese language website marketed tests and a mineral supplement (dubbed an "anti-radiation" pill, and condemned by leading ... He was arrested in 2018 in Devon after the nerve agent attack on the Skripals when some police officers visited his home after ...
Praziquantel
Agents that induce or inhibit CYP3A4 such as phenytoin, rifampin, and azole antifungals will affect the metabolism of ... Angelucci, F.; Basso, A.; Bellelli, A.; Brunori, M.; Pica Mattoccia, L.; Valle, C. (August 2007). "The anti-schistosomal drug ... various cardiac arrhythmias, and hypotension The WHO states praziquantel is safe during pregnancy. Animal studies have failed ... Agents Chemother. 41 (6): 1256-9. doi:10.1128/AAC.41.6.1256. PMC 163896. PMID 9174180. ...
Management of atrial fibrillation
The agents work by prolonging the Effective Refractory Period (ERP) either by blocking sodium ions (Class I drugs) or by ... The anti-arrhythmic medications often used in either pharmacological cardioversion or in the prevention of relapse to AF alter ... as it is the only reliably effective method for relieving the symptoms of the arrhythmia and can be used when other methods ... Among patients with nonvalvular AF, anticoagulation with warfarin can reduce stroke by 60% while antiplatelet agents can reduce ...
Atypical antipsychotic
... but clinical experience with these newer agents is not as developed as that with the older agents. The mechanism of these ... The atypical anti-psychotic paliperidone was approved by the FDA in late 2006.[citation needed] The atypical antipsychotics ... cardiac arrhythmia, and pneumonia. Conventional antipsychotics may pose an even greater safety risk. No clear efficacy evidence ... Sexual adverse effects caused by some anti-psychotics are a result of an increase of prolactin. Sulpiride and Amisulpiride, as ...
United States responses to the COVID-19 pandemic
"Coronavirus: Anti-Lockdown Protests Grow Across US". US & Canada. BBC News. April 17, 2020. Archived from the original on April ... One of Didier's COVID-19 studies was later retracted by the International Journal of Antimicrobial Agents. On March 28, the FDA ... including fatal cardiac arrhythmias among other side effects. In late July, President Trump continued to promote the use of ... "Coronavirus: Anti-Lockdown Protests Grow Across US". BBC News. 17 April 2020. Archived from the original on 17 April 2020. ...
Inhalant
Anti-Drug Abuse Act of 1988 (Public Law 1QO-690, section 2404) (15 U.S.C. 2d57a(e)(2)). "US Nitrous Oxide Laws (alphabetically ... Other agents may have more direct effects at receptors, as inhalants exhibit a variety of mechanisms of action. The mechanisms ... Inhaling butane gas can cause drowsiness, unconsciousness, asphyxia, and cardiac arrhythmia. Butane is the most commonly ... Other alkyl nitrites were outlawed in the U.S. by Congress through the Anti-Drug Abuse Act of 1988. The law includes an ...
Darbepoetin alfa
Erythropoiesis-stimulating agents, World Anti-Doping Agency prohibited substances, Orphan drugs). ... arrhythmia, hypertension and congestive heart failure, and edema. A recent study has extended these findings to treatment of ... The advisory recommended caution in using these agents in cancer patients receiving chemotherapy or off chemotherapy, and ... "Information for Healthcare Professionals: Erythropoiesis Stimulating Agents (ESA)". Food and Drug Administration. Archived from ...
Radiation therapy
These medications were the first agents of what is known as radioimmunotherapy, and they were approved for the treatment of ... In 2002, the United States Food and Drug Administration (FDA) approved ibritumomab tiuxetan (Zevalin), which is an anti-CD20 ... heart arrhythmia and peripheral artery disease. Radiation-induced fibrosis, vascular cell damage and oxidative stress can lead ... of the radioactive agents being infused. Methods, techniques and devices are available to lower the occurrence of this type of ...
Domperidone
... , by acting as an anti-dopaminergic agent, results in increased prolactin secretion, and thus promotes lactation as ... van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC (November 2010). "Domperidone and ventricular arrhythmia or ... Furthermore, anti-nausea drugs, such as metoclopramide, which do cross the blood-brain barrier, may worsen the extrapyramidal ... "Domperidone: Anti-sickness medicine used to treat nausea and vomiting". 7 January 2020. "Domperidone 10mg Tablets - Summary of ...
Histamine intolerance
Incompatibility of anti-inflammatory and analgesic medications in persons with histamine intolerance: Anti-inflammatory / ... "Contrast agents release histamine. The reason why, in most cases, nothing happens when administering contrast media is that ... However, since many complaints such as headaches, migraines, bronchial asthma, hypotension, arrhythmia and dysmenorrhea ( ... In addition, adherence to a histamine-free diet 24 hours before x-ray studies with contrast agents is recommended for ...
Ozone
... is among the most powerful oxidizing agents known, far stronger than O2. It is also unstable at high concentrations, ... anti-inflammatory property, and quality of red pepper fruit from Capsicum baccatum". Ecotoxicology and Environmental Safety. ... "Ambient particulate air pollution and cardiac arrhythmia in a panel of older adults in Steubenville, Ohio". Occupational and ... Oxidizing agents, Homonuclear triatomic molecules, Gases with color, Pollution, Air pollution, Pages that use a deprecated ...
Sergei Korolev
The purported reason was to protect him from foreign agents from the United States. As a result, the Soviet people didn't ... In 1964 doctors diagnosed him with cardiac arrhythmia. In February he spent ten days in the hospital after a heart problem. ... Arrested on a false official charge as a "member of an anti-Soviet counter-revolutionary organization" (which would later be ...
Quinine
As a flavouring agent in drinks, quinine is limited to less than 83 parts per million in the United States, and 100 mg⁄l in the ... Sappington's Anti-Fever Pills" across Missouri. Demand became so great that within three years, Dr. Sappington founded a ... In people with atrial fibrillation, conduction defects, or heart block, quinine can cause heart arrhythmias, and should be ... Quinine is sometimes detected as a cutting agent in street drugs such as cocaine and heroin. Quinine is used as a treatment for ...
Cardiac glycoside
Anti-Cancer Agents in Medicinal Chemistry. 13 (7): 1069-1087. doi:10.2174/18715206113139990304. PMID 23537048. S2CID 1537056. " ... Cardiac glycosides have long served as the main medical treatment to congestive heart failure and cardiac arrhythmia, due to ... Their beneficial medical uses are as treatments for congestive heart failure and cardiac arrhythmias; however, their relative ... On the other hand, cardiac arrhythmia are changes in heart rate, whether faster (tachycardia) or slower (bradycardia). ...
Acute liver failure
... anti-HAV IgM, HBSAg, anti-HBc IgM, anti-HCV Autoimmune markers: ANA, ASMA, LKMA, immunoglobulin levels Ceruloplasmin level ( ... Vasoconstrictive agents (especially vasopressin) should be avoided. Pulmonary edema and pulmonary infections are commonly seen ... cardiac arrhythmia or arrest and respiratory failure. The median time to death after admission was 5 days. Intravenous N- ... Hypotension should be treated preferentially with fluids, but systemic vasopressor support with agents such as epinephrine, ...
Methylprednisolone
In patients with diabetes, increased requirements of insulin or oral hypoglycemic agents. Fluid and electrolyte disturbances: ... Methylprednisolone (Depo-Medrol, Medrol, Solu-Medrol) is a synthetic glucocorticoid, primarily prescribed for its anti- ... arrhythmias, and possible hyperlipidemia. Dermatologic: impaired wound healing, petechiae and ecchymoses, thinning of the skin ...
Atrial fibrillation
Agents associated with a moderately increased risk include nonsteroidal anti-inflammatory drugs (e.g., ibuprofen), ... It may also start as other forms of arrhythmia such as atrial flutter that then transform into AF. Episodes can be asymptomatic ... For those at more than low risk, experts generally recommend an anti-clotting medication. Anti-clotting medications include ... "FDA approves anti-clotting drug Savaysa". FDA. 8 January 2015. Archived from the original on 19 June 2016. Retrieved 23 June ...
Septic shock
This is called compensatory anti-inflammatory response syndrome (CARS). Both the inflammatory and anti-inflammatory reactions ... Methylene blue has been found to work in cases resistant to the usual agents. This effect was first reported in the early 1990s ... Dopamine may cause rapid heart rate and arrhythmias, and is only recommended in combination with norepinephrine in those with ... Both pro-inflammatory and anti-inflammatory responses play a role in septic shock. Septic shock involves a widespread ...
Adenosine
... is believed to be an anti-inflammatory agent at the A2A receptor. Topical treatment of adenosine to foot wounds in ... This includes any re-entrant arrhythmias that require the AV node for the re-entry, e.g., AV reentrant tachycardia (AVRT) and ... Methotrexate's anti-inflammatory effect may be due to its stimulation of adenosine release. In general, adenosine has an ... Because of the effects of adenosine on AV node-dependent SVTs, adenosine is considered a class V antiarrhythmic agent. When ...
Salbutamol
While preferred over agents such as atosiban and ritodrine, its role has largely been replaced by the calcium channel blocker ... The 1972 Munich Olympics were the first Olympics where anti-doping measures were deployed, and at that time β2 agonists were ... Other symptoms may include tachycardia, arrhythmia, flushing of the skin, myocardial ischemia (rare), and disturbances of sleep ...
Furosemide
It is often viewed as a first-line agent in most people with edema caused by congestive heart failure because of its anti- ... increased risk of ventricular arrhythmias with amisulpride, sertindole, or pimozide (avoid with pimozide) if hypokalemia occurs ... It is on the World Anti-Doping Agency's banned drug list due to concerns that it may mask other drugs. It has also been used in ... "WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST 2022" (PDF). 2022. p. 12. Archived (PDF) from the original on 10 ...
Sepsis
However, these agents may precipitate prolongation of the QT interval and consequently provoke a ventricular arrhythmia such as ... Cross AS (January 2014). "Anti-endotoxin vaccines: back to the future". Virulence. 5 (1): 219-225. doi:10.4161/viru.25965. PMC ... Paralytic agents are not suggested for use in sepsis cases in the absence of ARDS, as a growing body of evidence points to ... The usage of prokinetic agents should be reassessed daily and stopped if no longer indicated. Sepsis will prove fatal in ...
Results of search for 'su:{Anti-arrhythmia agents.}' › WHO HQ Library catalog
Management of cardiac arrhythmias during pregnancy. Current concepts
Fortunately, malignant arrhythmias during the course of normal gestation are rare, and the relatively common complaint of ... Cardiac arrhythmia is one of the most common reasons for cardiac consultation during pregnancy. ... palpitations is usually due to benign arrhythmias. However, in pregnant patients w … ... Anti-Arrhythmia Agents / adverse effects * Anti-Arrhythmia Agents / therapeutic use* * Arrhythmias, Cardiac / complications ...
Drawipas
-
Anti-Arrhythmia Agents, ATC:C01BB03
Fire Fighter Fatality Investigation Report F99-15 | NIOSH | CDC
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients...
Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Physiological Effects of Drugs. Anti-Arrhythmia Agents ... Antihypertensive Agents. Enzyme Inhibitors. Ophthalmic Solutions. Pharmaceutical Solutions. Anticoagulants. Plasma Substitutes ... the patient was instructed to discontinue taking the medication and a nonsteroidal anti-inflammatory drug was prescribed. ...
digoxin | C41H64O14 | ChemSpider
Portal LIS - Localizador de Informação em Saúde
Education, Medical, Continuing, Atrial Fibrillation/therapy, Anti-Arrhythmia Agents, Instructional Film and Video, Webcast, ... Education, Medical, Continuing, Atrial Fibrillation/therapy, Anti-Arrhythmia Agents, Instructional Film and Video, Webcast ... Education, Medical, Continuing, Atrial Fibrillation/therapy, Stroke/prevention & control, Anti-Arrhythmia Agents, Symptoms in ...
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and...
Anti-Arrhythmia Agents /therapeutic use; Atrial Fibrillation /drug therapy /surgery; Catheter Ablation; Humans ... with development of a new arrhythmia and total proportion with any arrhythmia while on study medication were extracted. ... For RFA success rate (disappearance of arrhythmia) after a single procedure or after one or more procedures within the study ... Proportions of patients that had new or recurrent arrhythmia and those who required repeat ablation procedures were calculated ...
Drug Interactions Affecting Antiarrhythmic Drug Use - Fingerprint - Mayo Clinic
Intravenous Lidocaine Infusion for the Management of Early Postoperative Pain: A Comprehensive Review of Controlled Trials<...
Anti-Arrhythmia Agents Medicine & Life Sciences 22% * Acute Pain Medicine & Life Sciences 20% ... anti-hyperalgesic effects, anti-inflammatory effects, side effects, and role of intravenous lidocaine in the management of ... anti-hyperalgesic effects, anti-inflammatory effects, side effects, and role of intravenous lidocaine in the management of ... anti-hyperalgesic effects, anti-inflammatory effects, side effects, and role of intravenous lidocaine in the management of ...
Narrow complex tachycardia resident survival guide - wikidoc
Do not initiate treatment with anti-arrhythmic agents in a patient with undocumented arrhythmia. ... Consider trying different types of anti-arrhythmic agents in case the SVT is refractory; however, closely monitor the blood ... Type of Arrhythmia. EKG (lead II)†. Clues Sinus tachycardia. Onset and termination: gradual. Rhythm: regular. Rate: ,220 minus ... no other cause of arrhythmia identified ▸ Verapamil (Class I, level of evidence C). OR. ▸ Diltiazem (Class I, level of evidence ...
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multi-centre, randomized,...
Anti-Arrhythmia Agents Medicine & Life Sciences 78% * Atrial Fibrillation Medicine & Life Sciences 77% ... The primary end-point of the study was the absence of any recurrence of atrial arrhythmia lasting ,30s in the 1-year follow-up ... The primary end-point of the study was the absence of any recurrence of atrial arrhythmia lasting ,30s in the 1-year follow-up ... The primary end-point of the study was the absence of any recurrence of atrial arrhythmia lasting ,30s in the 1-year follow-up ...
DGIdb - VERAPAMIL Drug Record
anti-arrhythmia agents. Year of Approval. 1981. FDA Approval. approved. Drug Class. Small Molecule. ... Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr ... Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that ... and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents., J Med Chem ...
Boveda, S.<...
Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular ... Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular ... Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular ...
The Effect of Antiarrhythmic Drugs on the Ventricular Fibrillation Waveform - Fingerprint
- Ulster University
School of Medicine - Research output - Sefako Makgatho Health Sciences University
Search of: Acetaminophen AND postoperative AND pain relief AND after AND VAS - Results by Topic - ClinicalTrials.gov
DeCS
Agents, Anti-Arrhythmia Agents, Antiarrhythmia Anti Arrhythmia Agent Anti Arrhythmia Agents Anti Arrhythmia Drug Anti ... Agents, Anti-Arrhythmia. Agents, Antiarrhythmia. Agents, Antifibrillatory. Anti Arrhythmia Agent. Anti Arrhythmia Agents. Anti ... Anti Arrhythmic Anti Arrhythmics Anti-Arrhythmia Agent Anti-Arrhythmia Drug Anti-Arrhythmia Drugs Anti-Arrhythmic Anti- ... Anti Arrhythmia Drugs. Anti Arrhythmic. Anti Arrhythmics. Anti-Arrhythmia Agent. Anti-Arrhythmia Drug. Anti-Arrhythmia Drugs. ...
IMSEAR at SEARO: Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.
Anti-Arrhythmia Agents. en_US. dc.subject.mesh. Arrhythmias, Cardiac --chemically induced. en_US. ... Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs. Indian Journal of Physiology and ... The effect of glucagon in arrhythmias induced by coronary artery occlusion and ouabain was studied in dogs. Intravenous ... Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.. en_US. ...
Polyunsaturated Fatty Acids - SUPP.AI by AI2
DGIdb - BEPRIDIL Drug Record
anti-arrhythmia agents. Drug Class. small molecule. Drug Indications. Antihypertensive Agents. Drug Indications. Anti- ... mixed effects model analysis of the pharmacokinetics of routinely administered bepridil in Japanese patients with arrhythmias ... mixed effects model analysis of the pharmacokinetics of routinely administered bepridil in Japanese patients with arrhythmias ...
Industrial Chemical - N Methyl 2 Pyrrolidone Lr Grade Wholesale Trader from Mumbai
... an anti-arrhythmia drug, an analgesic and a fertilizer. It is a magnesium salt and a metal sulfate. ... Glyoxal is used in the textile industry as an ingredient in permanent press fabrics, as a stabilizing agent in rayon and other ... It acts as a solubilizer and cross-linking agent in polymer chemistry. Further, it is used as a fixative for histology to ... It has a role as an anticonvulsant, a cardiovascular drug, a calcium channel blocker, an anaesthetic, a tocolytic agent, ...
PRIME PubMed | Effects of benzyltetrahydropalmatine on potassium currents in guinea pig and rat ventricular myocytes
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary A Report...
PMID- 21949453
Anti-Arrhythmia Agents) RN - 0 (Estrenes) RN - 80177-51-1 (Org 7797) SB - IM MH - Animals MH - Anti-Arrhythmia Agents/* ... Anti-Arrhythmia Agents) RN - 64706-54-3 (Bepridil) SB - IM MH - Action Potentials/drug effects MH - Animals MH - Anti- ... Anti-Arrhythmia Agents) RN - 0 (Pyrimidinones) RN - 130656-51-8 (MS 551) RN - 1951-25-3 (Amiodarone) SB - IM MH - Aged MH - ... Anti-Arrhythmia Agents) RN - 0 (Piperidines) RN - 0 (Potassium Channels) RN - 0 (Pyridines) RN - 113558-89-7 (E 4031) SB - AIM ...
Department of Biological and Biomedical Sciences - Projects
- ResearchOnline
Schill, M. R.<...
Yoshinori Katsumata - Research output - Keio University
Anti-Arrhythmia Agents 28% 8 Citations (Scopus) * Visualization of the electrophysiologically defined junction between the ... journal of arrhythmia. 36, 1, p. 193-196 4 p.. Research output: Contribution to journal › Article › peer-review ... journal of arrhythmia. 34, 4, p. 465-468 4 p.. Research output: Contribution to journal › Article › peer-review ...
Sinus Node Dysfunction Medication: Anticholinergic Agents, Beta1/Beta2 Adrenergic Agonists, Cardiovascular, Other
This ECG shows sinus arrhythmia at a rate of 65-75 beats per minute. The P waves all originate from the sinus node (SN) because ... Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia ... Anticholinergic Agents. Class Summary. Atropine, by vagolytic effect, increases the heart rate. Although it may also be used ... The ECG shows sinus arrhythmia (bradycardia) at a rate of 50-79 beats per minute, with a PR interval of 136 ms. Two junctional ...
Cardiac ElectrophysiologyJournal of arrhythmiaRecurrence of atrialCongestive heart fAtrial flutterCardiovascularPatientsSustained ventricularAmiodaroneVentricular tachycardiaDigoxinAnalgesicHigh-dose steroidsIndicationsHypotensionNonsteroidalHumansAntihypertensive agentNSAIDsLidocaineInhibitionDoseInhibitorPreventionTreatmentPotentHypertensionEfficacyHeartAntiplatelet agentsSympathomimetic agentsBlockadeSymptomsCalciumTherapyMedicationsThyroidPalpitationsBeta blockersOverdoseIncreasesPregnancyPharmaceuticalAntithromboticSignificant
Cardiac Electrophysiology1
- Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. (vub.be)
Journal of arrhythmia1
- journal of arrhythmia. (elsevier.com)
Recurrence of atrial1
- For AAD the proportions of patients with recurrence of atrial fibrillation, with development of a new arrhythmia and total proportion with any arrhythmia while on study medication were extracted. (york.ac.uk)
Congestive heart f2
- Their continued efficacy in treatment of congestive heart failure and as anti-arrhythmic agents is well appreciated. (umn.edu)
- Hawthorn is one of the most used herbs for diseases of the heart, such as arrhythmia, congestive heart failure, chest pain, and blood pressure problems. (whatcure.com)
Atrial flutter2
- 0.001) ablation group patients had atrial arrhythmia recurrence (four patients had atrial flutter, 26 patients AF). (elsevier.com)
- Two main categories of atrial arrhythmias are CTI-dependent atrial flutter and non-CTI dependent atrial tachycardia. (sense-studios.com)
Cardiovascular5
- Serious adverse effects include cardiovascular block and arrhythmias, neuro-excitability and hypersensitivity, although the frequency of these are not known. (elsevier.com)
- 3) Anti-hypertensives: Hypertension which is the most common of all cardiovascular diseases and it has affected nearly 40 million people in the US. (rroij.com)
- It has a role as an anticonvulsant, a cardiovascular drug, a calcium channel blocker, an anaesthetic, a tocolytic agent, an anti-arrhythmia drug, an analgesic and a fertilizer. (meixi-mgo.com)
- Hundreds of studies are confirming its anti-inflammatory, anti-oxidant, anti-carcinogenic, anti-thrombotic, and cardiovascular protective effects. (whatcure.com)
- Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand published a review 'The protective role of curcumin in cardiovascular diseases' which showed that anti-inflammatory effects of curcumin may have the possibility of preventing arrhythmias. (whatcure.com)
Patients20
- However, in pregnant patients with organic heart disease, arrhythmias are often triggered by the haemodynamic burden of pregnancy and may be the first manifestation of the disease. (nih.gov)
- Antiarrhythmic drug therapy is indicated in such patients only in symptomatic or haemodynamically significant arrhythmias. (nih.gov)
- Proportions of patients that had new or recurrent arrhythmia and those who required repeat ablation procedures were calculated. (york.ac.uk)
- Anti-inflammatory agents are administered to patients with subacute granulomatous thyroiditis. (medscape.com)
- HA741 trade name] is indicated as a pharmacokinetic enhancer for protease inhibitors when these are used in combination therapy with other antiretroviral agents for the treatment of HIV-1 infected patients. (who.int)
- Conclusion: Ablation therapy combined with antiarrhythmic drug therapy is superior to antiarrhythmic drug therapy alone in preventing atrial arrhythmia recurrences in patients with paroxysmal or persistent AF in whom antiarrhythmic drug therapy has already failed. (elsevier.com)
- 2006, Nonlinear mixed effects model analysis of the pharmacokinetics of routinely administered bepridil in Japanese patients with arrhythmias. (wustl.edu)
- After an initial loading dose, 200 mg/day in many patients maintains arrhythmia control and minimizes the frequency of side effects. (elsevier.com)
- Amiodarone is a safe and efficacious antiarrhythmic agent when lower dosages are given to patients who are closely monitored and subject to careful follow-up. (elsevier.com)
- It would be helpful for clinicians and patients if the mechanism of arrhythmias could be identified via ECGs with a high degree of certainty, according to Dr Arunashis Sau (Imperial College London, UK) [1]. (sense-studios.com)
- Beta blockers agents in 1960s brought major changes for treatment of hypertension or angina pectoris patients. (rroij.com)
- These agents may be of benefit in patients whose conditions have not responded to steroids or in patients unable to tolerate prednisone. (medscape.com)
- In this setting, the optimal strategies for prevention of thrombotic events and choice of antithrombotic agents for management of pre-existing or new thrombotic events in patients with COVID-19 are of utmost importance. (thieme-connect.de)
- 4 ] [ 8 ] Some important considerations for the choice and dose of antithrombotic agents are the urgency for need of invasive procedures (e.g., for patients in the intensive care unit [ICU]), considerations for management of acute impairment of renal and liver function, and drug-drug interactions between investigational COVID-19 therapies and antithrombotic agents. (thieme-connect.de)
- n\nConclusion: High dose intravenous prednisolone might cause different types of arrhythmias in MS patients. (ainhibitor.com)
- The pivotal study evaluated the combination of KEYTRUDA, Merck's anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, versus chemotherapy (treatment of physician's choice of doxorubicin or paclitaxel) for patients with advanced endometrial carcinoma following at least one prior platinum-based regimen in any setting. (merck.com)
- As with other sympathomimetic agents CETAL SINUS should be used with caution in patients with hypertension, heart disease, diabetes, hyperthyroidism, elevated intraocular pressure and prostatic enlargement. (eipico.com.eg)
- Patients initially received gemcitabine 1000 mg/m 2 alone on days 1, 8 and 15 every 28-days for a total of six cycles (single agent cohort), and after protocol amendment a combination therapy with gemcitabine 1000 mg/m 2 and cisplatin 25 mg/m 2 on days 1 and 8 was administered every 21 days for a total of eight cycles (combined regimen cohort). (biomedcentral.com)
- The first 9 patients received single-agent gemcitabine. (biomedcentral.com)
- La réanimation agressive, la prise en charge nutritionnelle, l'excision chirur- gicale complète des plaies infectées, la fermeture rapide des plaies, les greffes et la mise au point d'une chimiothérapie locale et systémique efficace ont permis d'améliorer grandement le taux de morbidité et de mortalité chez les patients brûlés. (who.int)
Sustained ventricular1
- For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. (pharmacycode.com)
Amiodarone2
- Prospective interventional studies or studies with cost data that related to treatment of ventricular tachycardia and atrial fibrillation with AAD therapy (amiodarone, dofetilide, propafenone, sotalol or flecainide agents) were eligible for inclusion. (york.ac.uk)
- Amiodarone-induced arrhythmia is rare, with frequency of 0.3% in one study. (elsevier.com)
Ventricular tachycardia1
- n\nThe most important cardiac selleck inhibitor arrhythmias including ventricular tachycardia, sinus arrest, and sinus exit block. (ainhibitor.com)
Digoxin1
- Studies are confirming that hawthorn "may be an alternative treatment medication for arrhythmias induced by digoxin toxicity in humans. (whatcure.com)
Analgesic4
- Rarely, high-dose steroids and narcotic analgesic agents are used for extremely painful or recurrent life-threatening hyperthyroidism. (medscape.com)
- f. has been widely used in clinical practice due to its good anti-inflammatory and analgesic activities. (bvsalud.org)
- chili pepper extract and neuropeptide releasing agent selective for primary sensory peripheral neurons, used to experimentally manipulate substance P and other tachykinins, and as an analgesic for Herpes zoster infection. (medindex.am)
- These effects may result in analgesic, antipyretic, and anti-inflammatory activities. (medscape.com)
High-dose steroids1
- disturbances like sphincter and bowel problems have more chance to develop arrhythmias while receiving high dose steroids. (ainhibitor.com)
Indications1
- Longstanding use of antithrombotic agents for guideline-recommended indications should be, in general, continued. (thieme-connect.de)
Hypotension1
- Overdose noted as severe headache diarrhea hypotension cardiac arrhythmias. (genmed.pk)
Nonsteroidal3
- Pain is treated with nonsteroidal anti-inflammatory agents (NSAIDs). (medscape.com)
- None were critically ill, all responded quickly to treatment with nonsteroidal anti-inflammatories (NSAIDs), and several also received glucocorticoids. (medscape.com)
- Acute inflammation due to gout can be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or colchicine. (medscape.com)
Humans1
- The parameters for the model include body weight, breathing rate, and chemical-specific pharmacokinetic constants in humans, data typically available for pharmaceutical agents prior to large scale manufacturing. (cdc.gov)
Antihypertensive agent1
- A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. (rpsi.ir)
NSAIDs1
- Treatment consists of anti-inflammatory agents including NSAIDs, intravenous immunoglobulin (IVIG), and glucocorticoids. (medscape.com)
Lidocaine3
- Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. (pharmacycode.com)
- Previously used as anti-arrhythmic, intravenous lidocaine infusion is becoming popular for use in management of acute pain. (elsevier.com)
- In this article, we selected and reviewed randomized controlled trials to summarize the pharmacokinetics, antinociceptive effects, anti-hyperalgesic effects, anti-inflammatory effects, side effects, and role of intravenous lidocaine in the management of early postoperative pain. (elsevier.com)
Inhibition2
- This is an oral contrast agent used for the rapid and significant inhibition of the peripheral conversion of T4 to T3. (medscape.com)
- Inhibition of arrhythmias. (manguerascartagenasas.com)
Dose5
- Because agents that lower uric acid can precipitate attacks of gout, low-dose colchicine is typically used as prophylaxis (usually for 6 months) when such therapy is initiated. (medscape.com)
- The most prominent drug-drug interactions with investigational COVID-19 therapies and antiplatelet agents include those occurring between lopinavir/ritonavir and agents such as clopidogrel (may need dose increase) or ticagrelor (may need dose reduction). (thieme-connect.de)
- Additionally, dose adjustment would be necessary for agents such as vitamin K antagonists (VKAs), apixaban, and betrixaban. (thieme-connect.de)
- 4 ] VKAs potentially have major drug interactions when prescribed with investigatory agents such as ribavirin, interferon, methylprednisolone, and azithromycin, which often necessitates close international normalized ratio (INR) monitoring, dose adjustment, or using alternative options. (thieme-connect.de)
- In the single-agent cohort with gemcitabine the median relative dose intensity (RDI) was 100% (IQR 88.3-100). (biomedcentral.com)
Inhibitor2
- For children who are undergoing anti-tuberculosis treatment with rifampicin, higher dosages of ritonavir may be needed for pharmacokinetic enhancement of the combined protease inhibitor. (who.int)
- 2-ethylhexyl acrylate can be prepared with a high yield by esterification of acrylic acid with racemic 2-ethylhexanol in the presence of hydroquinone as a polymerization inhibitor and a strong acid such as methanesulfonic acid by reactive distillation using toluene as an azeotroping agent. (indiamart.com)
Prevention1
- Agents used for the treatment or prevention of cardiac arrhythmias. (bvsalud.org)
Treatment8
- Drug treatment of cardiac arrhythmias / edited by Lawrence A. Gould. (who.int)
- This review focuses on recent findings on cellular pharmacology of cardiac glycosides as they relate to treatment of human cancer and attempts to explain why these agents have been overlooked in the past. (umn.edu)
- 2) Anti-arrhythmics: These agents are used for treatment of Arrhythmia in which the rhythmic contraction of the heart is interrupted. (rroij.com)
- Flecainide is a class Ic antiarrhythmic agent used in the treatment of supraventricular and ventricular arrhythmias. (amjcaserep.com)
- Antimalarial agents have previously been used for the treatment of rheumatoid arthritis. (medscape.com)
- 3. Participants who have received non-vaccination treatment for SARS-CoV-2 within 30 days prior to study entry, e.g., remdesivir, Paxlovid, molnuparivir, SARS-CoV-2 monoclonal Abs, convalescent serum, or other anti- SARS-CoV-2 agents with national regulatory approval, zinc, or Andrographis paniculata. (who.int)
- Arch Oncology is an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers. (missouritechnology.com)
- Single-agent chemotherapy with gemcitabine [ 11 ] has been the standard of care in the treatment of inoperable adenocarcinoma of the pancreas prior to more efficacious regimens such as FOLFIRINOX and gemcitabine plus nab-paclitaxel. (biomedcentral.com)
Potent1
- It has also been shown to improve thyroid and adrenal function and is a potent anti-arrhythmia and anti-tachycardia agent. (jackmizesupport.com)
Hypertension1
- If hypertension is a consequence of corticosteroid therapy, consider immunomodulating medications as steroid-sparing agents to help control hypertension. (medscape.com)
Efficacy1
- Prospective and retrospective studies of any interventional design in which RFA was used to treat cardiac arrhythmias and safety, efficacy or cost related to ablation were evaluated were eligible for inclusion. (york.ac.uk)
Heart1
- In cases where organic heart disease or any other cause for arrhythmia is identified, the underlying disease should be treated first. (nih.gov)
Antiplatelet agents1
- 7 ] For the most part, parenteral antiplatelet agents have a safe interaction profile. (thieme-connect.de)
Sympathomimetic agents4
- Concomitant use of CETAL SINUS with tricyclic antidepressants, sympathomimetic agents (such as decongestants, appetite suppressants and amfetamine-like psychostimulants) or with monoamine oxidase inhibitors, which interfere with the catabolism of sympathomimetic amines, may occasionally cause a rise in blood pressure (see Contraindications ). (eipico.com.eg)
- Enhanced sarcoplasmic reticulum ca: moderate sympathomimetic agents. (manguerascartagenasas.com)
- Gjedde s, crystalloids, clonidine: moderate sympathomimetic agents. (manguerascartagenasas.com)
- Alpha-Blockers: moderate sympathomimetic agents. (manguerascartagenasas.com)
Blockade2
- Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (bvsalud.org)
- Adjunctive anti-ischemic therapies such as intravenous nitroglycerin or beta blockade can be useful to minimize ischemia. (blogspot.com)
Symptoms1
- Therapy is directed toward reducing the signs and symptoms of the hyperthyroidism with beta blockers or iodine agents. (medscape.com)
Calcium1
- A calcium channel blocker that is a class IV anti-arrhythmia agent. (nih.gov)
Therapy2
- Antiarrhythmic drug therapy is indicated when arrhythmias persist or as a prophylactic measure. (nih.gov)
- In cancer survivors with cancer therapy-induced cardiomyopathy, AF often occurs, with most of the arrhythmias likely to develop secondary to the cardiomyopathy. (jefferson.edu)
Medications1
- Interaction with other arrhythmia medications can be potentially dangerous. (sukury.com)
Thyroid2
- 7) Anti-thyroid drugs and thyroid hormones: Antithyroid drugs are used to treat an overactive thyroid (hyperthyroidism) which is caused by Graves' disease. (rroij.com)
- Annotated normal thyroid function, the antidiabetic agents. (manguerascartagenasas.com)
Palpitations1
- Fortunately, malignant arrhythmias during the course of normal gestation are rare, and the relatively common complaint of palpitations is usually due to benign arrhythmias. (nih.gov)
Beta blockers1
- Simultaneous use of Zofran with antibiotics, beta-blockers, anti-fungal or anti-arrhythmic agents increases the risk of arrhythmias. (happyfamilystoreonline.com)
Overdose1
- Overdose can cause low blood pressure and cardiac arrhythmia. (whatcure.com)
Increases1
- The lipid-lowering agent fenofibrate reduces serum urate 19% and increases clearance by 36% at 200 mg/day. (medscape.com)
Pregnancy2
Pharmaceutical2
Antithrombotic1
- The present review aims to describe the pathophysiology of DE and to summarize the currently available pharmacological strategies to prevent and treat DE in the setting of MI, especially focusing on antithrombotic, antiinflammatory and vasodilator agents. (ox.ac.uk)
Significant3
- Given the adverse effect profile of corticosteroids, methotrexate has recently received significant attention as either a corticosteroid alternative or a corticosteroid-sparing agent. (medscape.com)
- 4. Known current, or past, history of clinically significant arrhythmia. (who.int)
- It ated with cardiac arrhythmias, neurological functions as the first line of defence protec- damage and significant long and short-term ting against the invasion of foreign bodies morbidity. (who.int)